Menu Back toThe Journey to a Modernization of Analytics

DIA 2021 Global Annual Meeting


The Journey to a Modernization of Analytics

Session Chair(s)

Peter  Mesenbrink, PhD

Peter Mesenbrink, PhD

  • Executive Director of Biostatistics
  • Novartis Pharmaceuticals Corporation, United States
This forum will present on the statistical analytics assessment framework based on risk as to the factors that contribute to confidence or trust for various statistical software, tools, and applications. A panel of experts will provide their experiences.
Learning Objective : Describe best practices to achieve a modernization of analytics within biostatistics and data science.

Speaker(s)

Peter  Mesenbrink, PhD

Changing How We Use Modern Analytics in Clinical Drug Development

Peter Mesenbrink, PhD

  • Executive Director of Biostatistics
  • Novartis Pharmaceuticals Corporation, United States
Daniel  Woodie, MS

Industry Update

Daniel Woodie, MS

  • Senior Scientist, Statistical Programming
  • Merck & Co., Inc., United States
Andy  Nicholls, MSc

Industry Update

Andy Nicholls, MSc

  • Senior Director, Head of Statistical Data Sciences
  • GlaxoSmithKline, United Kingdom
Min  Lee

Industry Update

Min Lee

  • Director of Biostatistical Programming
  • Amgen, United States